Ipamorelin and CJC-1295 without DAC (modified GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and the dynamics of pituitary signaling.
Browse nearby entries from the full catalog, starting with Peptide Supplier.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantIpamorelin and CJC-1295 without DAC (modified GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and the dynamics of pituitary signaling. Ipamorelin is a selective pentapeptide growth hormone secretagogue that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), activating Gq/PLC- and calcium-dependent signaling pathways involved in GH release, while it shows only minimal interactions with other pituitary hormones in preclinical systems. CJC-1295 without DAC is a stabilized analogue of the growth hormone-releasing hormone (GHRH 1-29), which activates the GHRH receptor and stimulates adenylyl cyclase- and cAMP-mediated signaling pathways in somatotroph cells. Preclinical research uses the combined activation of GHS-R1a and GHRH receptors to investigate synergistic somatotrophic signaling, hypothalamic–pituitary feedback mechanisms, and peptide-mediated endocrine regulation.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.